Similar articles

• Primary prevention of cardiovascular disease risk factors: review and implications for population-based practice.

  Meininger JC. Meininger JC. Adv Pract Nurs Q. 1997 Fall;3(2):70-9. Adv Pract Nurs Q. 1997. PMID: 9432456 Review.
• Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.

  Dennison CR, Hughes S. Dennison CR, et al. J Cardiovasc Nurs. 2009 Jan-Feb;24(1):18-20. doi: 10.1097/01.JCN.0000343558.14237.70. J Cardiovasc Nurs. 2009. PMID: 19114796 Review. No abstract available.
• Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.

  U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Am J Nurs. 2002 Mar;102(3):67, 69-70. Am J Nurs. 2002. PMID: 11976531 Review. No abstract available.
• Time for results: a better way to reduce cardiovascular risk.

  Mola A, Lloyd M. Mola A, et al. Adv Nurse Pract. 2002 Apr;10(4):34-41; quiz 42-3. Adv Nurse Pract. 2002. PMID: 12418348 Review. No abstract available.
• [Declared knowledge, beliefs and practices for cardiovascular disease prevention in the French population].

  Lang T, Arveiler D, Ferrières J, Amouyel P, Bingham A, Ducimetière P, Sartori V, Ruidavets JB, Montaye M. Lang T, et al. Rev Epidemiol Sante Publique. 2001 Jun;49(3):239-48. Rev Epidemiol Sante Publique. 2001. PMID: 11427827 French. No abstract available.